Boston Scientific

Open: 59.94 Close: 59.94 Change: 0.0

The stock market through the eyes of an AI: Boston Scientific.

Are looking for the most relevant information about Boston Scientific? Investor spend a lot of time searching for information to make investment decisions in Boston Scientific. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Boston Scientific are: Boston, Scientific, acquire, Axonics, price, purchase, value, and the most common words in the summary are: boston, scientific, bloomberg, axonics, news, company, acquire, . One of the sentences in the summary was: Boston Scientific priced the acquisition at $71 per share. Other searches …

Concept Map

Semantic Network

Stock Summary

Boston Scientific develops, manufactures, and markets medical devices for use in various interventional medical specialties. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat.

Today's Summary

Boston Scientific priced the acquisition at $71 per share. Marlborough, Massachusetts-based Boston Scientific will acquire Axonics for about $3.7 billion in cash. The deal marks Boston Scientifics entry into sacral neuromodulation.

Today's News

Boston Scientific will acquire Axonics for about $3.7 billion in cash. Marlborough, Massachusetts-based Boston Scientific priced the acquisition at $71 per share. All the indices posted gains and seven out of 11 S&P 500 sectors posted nice to extraordinary gains. Boston Scientific aims to penetrate the sacral neuromodulation market. Boston Scientific to purchase medical tech firm Axonics for $3.7 billion. The purchase price comes to an equity value of about $3.7 billion, Marlborough, Massachusetts-based Boston Scientific said Monday in a statement. The deal marks Boston Scientifics entry into sacral neuromodulation. Boston Scientific has 45,000 employees as of Dec 22. Annual revenue of Boston Scientific is $12.7B as on Dec 31, 2022. Boston Scientific maintains a prohibited substance free workplace. Boston Scientific is proud to be an equal opportunity and affirmative action employer. Boston Scientific maintains a prohibited substance free workplace. Boston Scientific Corporation is acquiring Axonics, Inc. Boston Scientific expects to complete the transaction in the first half of 2024. Boston Scientific had annual revenue of $12.68B in 2022. Boston Scientific Corp. has signed an agreement to acquire medical technology company Axonics in a deal valued at approximately $3.7bn. The purchase price comes to an equity value of about $3 billion, Boston Scientific said Monday in a statement. The deal gives Boston Scientific access to a portfolio that delivers a device that delivers access to device that enables a product that delivers.

Stock Profile

"Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts."

Keywords

This document will help you to evaluate Boston Scientific without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Boston Scientific are: Boston, Scientific, acquire, Axonics, price, purchase, value, and the most common words in the summary are: boston, scientific, bloomberg, axonics, news, company, acquire, . One of the sentences in the summary was: Boston Scientific priced the acquisition at $71 per share. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #boston #scientific #bloomberg #axonics #news #company #acquire.